Rate of cognitive decline was even faster among widowed participants with higher β-amyloid levels at baseline.
A simple SVD score using MRI scans, may aid in identifying patients with SVD who are likely to develop cognitive decline.
The USPSTF states the balance of benefits and harms of cognitive impairment screening for older adults cannot be established due to lack of evidence.
In older adults with abdominal obesity, sustained levels of higher blood glucose are tied to a higher likelihood of experiencing cognitive decline, whereas in older adults without abdominal obesity, the hormone adiponectin appears to up the risk for cognitive decline.
Increased age, male gender, and the presence of baseline cerebral microbleeds is associated with increased risk for developing cerebral microbleeds in any location.
Compared with their peers, Asian patients with dementia were less likely to be prescribed antidementia drugs, and they received these drugs for fewer days per year.
Higher gamma-glutamyltransferase variability was found to be significantly associated with increased risk for dementia among patients with diabetes.
Treatment with statins in the elderly population is not associated with accelerated memory dysfunction, greater decline in global cognitive function, or brain volume changes over 2 years.
A physically and mentally active lifestyle may protect against frontotemporal dementia even in people at established genetic risk.
Left atrial enlargement with vs without atrial fibrillation was not found to be associated with greater cognitive decline over a 5-year period.